The Translational and Research Skills Development Core (Core D) will be the primary vehicle by which the University of Utah Molecular MedicineTranslational Research Center in Thrombosis (U2M2-TRCT) trains young investigators. Core D will take advantage of existing infrastructure at the University of Utah and, in doing so, will provide a unique training environment for MD, PhD, and MD-PhD scientists at various career stages. This includes utilization of the University of Utah Clinical Center in Translational Science (CCTS), four T32 programs, a HHMI med-to-grad PhD scientist training program, the MD-PhD program, and the Medical Student Summer research program. All of these programs are directed or co-directed by U2M2-TRCT investigators. Core D will use this infrastructure to rigorously prepare young investigators for bench to-bedside research careers related to metabolism and/or thrombosis. The Core provides an in-depth and cohesive education program for all types of young invesfigators. This curriculum includes specialized classes that focus on metabolism and thrombosis. Core D also includes individualized mentoring with U2M2-TRCT established scientists that will introduce young investigators to the ins-and-outs of basic and translational research. A primary objective of Core D will be to help young investigators generate preliminary data for competitive grant applications. In parallel, the young investigators will participate in grant writing workshops and research-in-progress sessions that provide a platform for presentation and critique of research plans. The U2M2-TRCT program already includes several young and emerging investigators who participated in preparing this submission. These investigators have previously trained with U2M2-TRCT senior scientists, have successfully applied and received young investigator awards, and are well on their way to independent research careers. Core D will continue to provide a fertile environment that fosters the development of these investigators and other MD, PhD, and MD-PhD trainees who will enter the program over the next several years.

Public Health Relevance

Patients with type 2 diabetes, obesity, or the metabolic syndrome are at increased risk for blood clots (thrombosis) caused by cells called platelets. Our studies will determine how metabolic factors in the blood and tissues (the metabolic milieu), such as high glucose and lipids, make platelets more prone to induce thrombosis, providing new insights into the treatment and management of diabetes and obesity.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HL112311-03
Application #
8656423
Study Section
Special Emphasis Panel (ZHL1)
Project Start
Project End
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
3
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Schwertz, Hansjörg; Rowley, Jesse W; Schumann, Gerald G et al. (2018) Endogenous LINE-1 (Long Interspersed Nuclear Element-1) Reverse Transcriptase Activity in Platelets Controls Translational Events Through RNA-DNA Hybrids. Arterioscler Thromb Vasc Biol 38:801-815
Morales-Ortíz, Jessica; Deal, Victoria; Reyes, Fiorella et al. (2018) Platelet-derived TLT-1 is a prognostic indicator in ALI/ARDS and prevents tissue damage in the lungs in a mouse model. Blood 132:2495-2505
Middleton, Elizabeth A; Rondina, Matthew T; Schwertz, Hansjorg et al. (2018) Amicus or Adversary Revisited: Platelets in Acute Lung Injury and Acute Respiratory Distress Syndrome. Am J Respir Cell Mol Biol 59:18-35
Morales-Ortíz, Jessica; Rondina, Matthew T; Brown, Samuel M et al. (2018) High Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-Like Transcript (TLT)-1 Are Associated With Acute Respiratory Distress Syndrome. Clin Appl Thromb Hemost 24:1122-1127
Manne, B K; Rondina, M T (2018) PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway: reply. J Thromb Haemost 16:1904-1905
Cloutier, Nathalie; Allaeys, Isabelle; Marcoux, Genevieve et al. (2018) Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration. Proc Natl Acad Sci U S A 115:E1550-E1559
Manne, B K; Münzer, P; Badolia, R et al. (2018) PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway. J Thromb Haemost 16:1211-1225
Fidler, Trevor P; Rowley, Jesse W; Araujo, Claudia et al. (2017) Superoxide Dismutase 2 is dispensable for platelet function. Thromb Haemost 117:1859-1867
Manne, Bhanu K; Xiang, Shang Chun; Rondina, Matthew T (2017) Platelet secretion in inflammatory and infectious diseases. Platelets 28:155-164
Campbell, Robert A; Vieira-de-Abreu, Adriana; Rowley, Jesse W et al. (2017) Clots Are Potent Triggers of Inflammatory Cell Gene Expression: Indications for Timely Fibrinolysis. Arterioscler Thromb Vasc Biol 37:1819-1827

Showing the most recent 10 out of 100 publications